Partners Investment logo

Partners Investment

Crunchbase
Crunchbase

Deals on record

4

Common Fundraising Type

Series A

AIGEN Sciences is an AI-driven company that develops small-molecule synthetic drugs for diseases with high unmet medical needs.

Equity
$8.8M
10/21/2024
Article
Adcentrx logo
Adcentrx

Biotechnology

Quan Capital logo
Partners Investment logo

Adcentrx Therapeutics is a biotech company developing next-generation Antibody-Drug Conjugate (ADC) therapies for cancer, utilizing its proprietary i-Conjugation™ technology.

Series A
$13M
12/06/2023
Article

Cytonus Therapeutics, Inc. is a biotechnology firm specializing in the development of novel therapies for metastatic tumors and the CNS, utilizing its proprietary Cargocyte™ Drug Delivery Platform.

Series A
$11.7M
12/04/2023
Article
Harbinger Health logo
Harbinger Health

Biotechnology

Flagship Pioneering logo
Pictet logo
Partners Investment logo
M&G logo

Harbinger Health is a biotechnology company that is developing a blood-based cancer screening product, utilizing machine learning and proprietary insights into cancer biology, with the aim to make cancer screening globally accessible, affordable, and reduce false positives.

Series B
$140M
09/28/2023
Article